Enable Accessibility
Enable Accessibility
Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts & Japan offices
History
Worldwide Offices
Executive Leadership
Positions
Takeda Global Headquarters
Design Concept
Where we work
Corporate Philosophy
Corporate Governance
Values and Corporate Governance
Board of Directors
Nomination Committee and Compensation Committee
Audit and Supervisory Committee and Internal Audit
Our Management
Charters and Reports, etc.
Risk & Crisis Management
Global Ethics & Compliance / Global Code of Conduct
Transparency Disclosures
EFPIA Disclosure Code Reports
Patient Group Disclosures
Contact Us
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
We will become a global, values-based, R&D-driven, biopharmaceutical leader
Learn more
Research & Development
Science Stories
Our Pipeline
Clinical Trials
Areas of Focus
Oncology
Rare Diseases
Neuroscience
Gastroenterology
Plasma-Derived Therapies
Vaccines
Alliances & Partnerships
Takeda Digital Ventures
Our Products
Manufacturing
Innovation Story
Access to Medicines
Our Approach and Our Position
Hear from Patients
Driving Impact with Partners
Pre- Approval Access
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Third Party Risk Management
Become a Takeda Supplier
Responsible Procurement
Purchase Orders and Invoices
Takeda Supplier Solutions Portal
Contact us
T-CiRA
About T-CiRA
Leaders Message
What we do
Portfolios
Projects
Inside T-CiRA
Research Achievements
Future of iPSC
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
Two centuries. Countless innovations. One vision.
Learn more
All Stories
Corporate Responsibility
Takeda's CSR
Takeda is committed to addressing the world’s biggest challenges to sustainable development over the long term.
LEARN MORE
Programs in Action
Takeda Chair in Global Child Health
Takeda Initiative for the Global Fund
Global CSR Program
Apply for Funding
Frequently Asked Questions
Leaders Driving Change
Purpose led-Sustainability at Takeda
Patient
People
Planet
Governance
Reporting on Sustainability
TAKEDA LIFE THEATER, Embark on a journey of discovery inside the human body!
LEARN MORE
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
HOME
Investors
IR Events
Share:
Investors
Financial Highlights
Quarterly Results
IR Events
Annual/Quarterly Securities Report
SEC Filings
Annual Shareholders Meetings
IR Calendar
Stock・Credit Rating
Retail Investors
IR Contact
IR Events FY2022 (April 2022-March 2023）
TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data
(7:00pm – 7:45pm EDT on March 18, 2023)
Webcast
Presentation
QDENGA Investor call
(7:00pm – 8:30pm EDT on Wednesday March 15, 2023)
Webcast
Presentation
Cowen 43
rd
Health Care Conference
(1:30pm – 2:00pm EST on March 6, 2023)
Webcast
Retail Investor Event
(7:00pm – 8:00pm JST on February 22, 2023)
Presentation
41
st
Annual J.P. Morgan Healthcare Conference
(4:30pm – 5:10pm PST on January 9, 2023)
Presentation
Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics
(5:30pm – 6:15pm EST on Wednesday December 13, 2022)
Presentation
Webcast
Jefferies London Healthcare Conference
(8:30am – 9:00am EST on Tuesday November 15, 2022
1:30pm – 2:00pm GMT on Tuesday November 15, 2022)
This event was closed.
Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)
(1:00pm JST on October 4, 2022)
Presentation
Webcast
Morgan Stanley Healthcare Conference
(2:50pm – 3:20pm EDT on September 12, 2022)
Webcast
Jefferies Healthcare Conference
(3:00pm – 3:25pm EDT on June 9, 2022)
This event was closed.
IR Events Archive
FY2021 (April 2021-March 2022)
FY2020 (April 2020-March 2021)
FY2019 (April 2019-March 2020)
FY2018 (April 2018-March 2019)
FY2017 (April 2017-March 2018)
FY2016 (April 2016-March 2017)
FY2015 (April 2015-March 2016)
FY2014 (April 2014-March 2015)
FY2013 (April 2013-March 2014)
FY2012 (April 2012-March 2013)
TOP
Close
